BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
69.37
+1.22 (1.79%)
At close: Oct 27, 2026, 4:00 PM EDT
69.07
-0.30 (-0.43%)
Pre-market: Oct 28, 2026, 8:04 AM EDT
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +58.57% | Oct 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $87 | Buy | Maintains | $87 | +25.41% | Oct 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +72.99% | Oct 19, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $104 → $102 | Buy | Reiterates | $104 → $102 | +47.04% | Oct 19, 2026 |
| Citi | Citi | Hold Maintains $94 → $91 | Hold | Maintains | $94 → $91 | +31.18% | Oct 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $102 | Buy | Maintains | $102 | +47.04% | Oct 15, 2026 |
| UBS | UBS | Buy Initiates $82 → $92 | Buy | Initiates | $82 → $92 | +32.62% | Oct 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +72.99% | Oct 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.